NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX) today announced the commercial launch of BRIUMVI™ (ublituximab-xiiy), for the treatment of relapsing forms of multiple ...
Ms. Dac brings more than 30 years of experience successfully executing product launches and scaling commercial organizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results